Nearly 30% of U.S. adults with hypertension but no heart disease were eligible for blood pressure-lowering therapy based on an updated clinical guideline, yet nearly half may remain untreated, researchers reported.Prioritizing antihypertensive therapy among eligible patients who remain untreated could prevent hundreds of thousands of all-cause and CV-related deaths over the next 10 years,

Nearly 30% of U.S. adults with hypertension but no heart disease were eligible for blood pressure-lowering therapy based on an updated clinical guideline, yet nearly half may…

New research suggests that a large percentage of U.S. adults eligible for hypertension treatment aren't getting it.